Indoco Remedies surges on getting USFDA’s nod for Olanzapine Tablets

06 Aug 2020 Evaluate

Indoco Remedies is currently trading at Rs. 236.95, up by 2.80 points or 1.20% from its previous closing of Rs. 234.15 on the BSE.

The scrip opened at Rs. 236.80 and has touched a high and low of Rs. 240.00 and Rs. 232.35 respectively. So far 9717 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 285.00 on 13-Apr-2020 and a 52 week low of Rs. 133.10 on 11-Oct-2019.

Last one week high and low of the scrip stood at Rs. 255.95 and Rs. 208.00 respectively. The current market cap of the company is Rs. 2190.87 crore.

The promoters holding in the company stood at 58.69%, while Institutions and Non-Institutions held 16.54% and 24.77% respectively.

Indoco Remedies has received approval from US Food and Drug Administration (USFDA) for its ANDA for Olanzapine Tablets USP 2.5mg, 5mg, 7.5 mg, 10mg, 15mg and 20 mg. The products are therapeutically equivalent to the Reference Listed Drug ‘Zyprexa’ of Eli Lilly.

Olanzapine is indicated for the treatment of schizophrenia and bipolar disorder. The drug may also be used in combination with other medication to treat depression and certain mental conditions. The US market size of Olanzapine Tablets is $65 million.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

243.00 3.60 (1.50%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×